The FDA: The good, the bad, and the alternative
Peter Fratarcangelo joins Jim Blasingame to talk about how his company provides drug research and support to the American drug industry and the FDA.
More interviews with Peter Fratarcangelo
Why Obamacare mandates are counter to reform